2012
DOI: 10.7314/apjcp.2012.13.2.647
|View full text |Cite
|
Sign up to set email alerts
|

Folate intake, Methylenetetrahydrofolate Reductase Polymorphisms in Association with the Prognosis of Esophageal Squamous Cell Carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
33
0
3

Year Published

2012
2012
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(37 citation statements)
references
References 33 publications
1
33
0
3
Order By: Relevance
“…Three studies presented results for ESCC and EAC separately [13][14][15][16] and five for ESCC only [17][18][19][20][21]. The remaining four did not differentiate histological type.…”
Section: Resultsmentioning
confidence: 97%
“…Three studies presented results for ESCC and EAC separately [13][14][15][16] and five for ESCC only [17][18][19][20][21]. The remaining four did not differentiate histological type.…”
Section: Resultsmentioning
confidence: 97%
“…Previous studies showed the folate intake and MTHFR C677T polymorphism was associated with the risk of several human cancer (Mayne et al, 2001;Chen et al, 2002, Jing et al, 2012. The activity of folate metabolic enzyme is involved in the methylation process of DNA, and recent experimental and epidemiologic studies show the MTHFR C677T polymorphism and folate status have a role in genomic DNA methylation (Friso et al, 2002;Wang et al, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…Genotyping was conducted by TaqMan assays using the ABI Prism 7911HT Sequence Detection System (Applied Biosystems, Foster City, CA). Primer, probes, and reaction conditions were those described in our previous study (Jing et al, 2012). Briefly, a total PCR reaction volume of 10 uL contained 200 ng of genomic DNA and 20 pmol of each primer.…”
Section: Blood Samples and Dna Collectionmentioning
confidence: 99%